Total medical devices industry deals worth $3.8bn were announced globally for February 2022, with the $556.1m private equity deal for 60.8% stake with Classys being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 63.1% over the previous month of $10.4bn and a drop of 76.2% when compared with the last 12-month average of $16.12bn.
In terms of number of deals, the sector saw a rise of 1.04% with 194 deals in February 2022 when compared to the last 12-month average of 192 deals.
In value terms, North America led the activity with deals worth $2.21bn in February 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDatamedical devices industry deals in February 2022: Top deals
The top five deals accounted for 40.7% of the overall value during February 2022.
The combined value of the top five deals stood at $1.56bn, against the overall value of $3.8bn recorded for the month.
The top five medical devices industry deals of February 2022 tracked by GlobalData were:
1) Bain Capital Private Equity $556.1m private equity deal for 60.8% stake in Classys
2) The $325m venture financing of Somatus by Anthem,Blue Venture Fund,Deerfield ManagementLP,Fidelity Management & Research,Flare Capital Partners,General Insuranceof India,Inova Health System,Longitude Capital Management Co,Optum Ventures,RA Capital Management and Wellington ManagementLLP
3) Altaris Capital Partners $241m private equity deal with IntriCon
4) The $227.57m acquisition of 9.07% stake in Cardiac Insight by Dreamtech
5) South Elm Investments B V $210m private equity deal with Micro Life Sciences
